Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 587.25M P/E - EPS this Y 13.60% Ern Qtrly Grth -
Income -44.05M Forward P/E -4.76 EPS next Y -41.20% 50D Avg Chg 1.00%
Sales 15.13M PEG -0.28 EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 1.72 EPS next 5Y 145.30% 52W High Chg -46.00%
Recommedations 1.60 Quick Ratio 57.03 Shares Outstanding 52.16M 52W Low Chg 28.00%
Insider Own 9.27% ROA -7.98% Shares Float 32.13M Beta 3.57
Inst Own 98.39% ROE -9.20% Shares Shorted/Prior 3.31M/3.25M Price 12.77
Gross Margin -251.04% Profit Margin -291.17% Avg. Volume 152,358 Target Price 67.50
Oper. Margin -155.36% Earnings Date Aug 7 Volume 62,386 Change -3.55%
About Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics, Inc. News
10/07/24 Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now
09/26/24 Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?
09/20/24 Lennar, Bitdeer, and More Stocks See Action From Activist Investors
09/17/24 RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc
06:33 PM Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks
09/13/24 Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?
08/16/24 Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors
08/07/24 Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
08/07/24 Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
07/22/24 Janux Therapeutics Announces Updates to Board of Directors
05/09/24 We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
05/08/24 Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
05/07/24 Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
04/30/24 Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
04/17/24 Take the Money and Run: 3 Overbought Stocks to Sell ASAP
04/16/24 These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
04/15/24 Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors
04/12/24 Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable
04/12/24 Why Janux Therapeutics Stock Is Crushing It This Week
04/11/24 Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
JANX Chatroom

User Image FlynancialAnalyst Posted - 2 days ago

Don't get it $TWST 'd, $JANX is looking $VERA special $XBI

User Image FlynancialAnalyst Posted - 2 days ago

$JANX $2.47B mc $XBI #ShortSqueeze name continues to impress, accumulation wk off 10 wk SMA just above key $40 level FOUNDER LED, 9.27% insider owned Pct of all funds long share at record highs & rising TrendEdge.app/asset/JANX

User Image StockConsultant Posted - 3 days ago

$JANX Janux Therapeutics stock nice move the 44.84 triple support area at https://stockconsultant.com/?JANX

User Image seet79 Posted - 6 days ago

@Kingjake26 this is a retail stock. Too many many people in with no clue. $JANX is the perfect stock basically- no engagement- nobody pays attention to the company and it keeps going higher-

User Image seet79 Posted - 6 days ago

$CAPR $SAVA short $JANX $SLNO long

User Image seet79 Posted - 1 week ago

$JANX news AH?

User Image Theflash88 Posted - 1 week ago

$JANX Ok Merck. Let’s get r done.

User Image uberkauft Posted - 1 week ago

$JANX Janux Therapeutics Inc. 14-Day RSI: 46.9 % from 52-Week Low: +669.0% % from 52-Week High: -33.8% Open Interest: 7,237 % Change: 0% Put/Call Ratio: 4.66 % Change: 0.0%

User Image JoshThe3rd Posted - 1 week ago

$JANX took a few on daily 50ma

User Image insiderbuyingselling Posted - 09/30/24

$JANX new insider selling: 307779 shares. http://insiderbuyingselling.com/?t=JANX

User Image Jaymuss Posted - 09/28/24

$JANX Why does janx get a market cap of 2.5 billion this early in their trials ? I saw that their earlier results lowered psa numbers in patients but as I understand it , there are other drugs that do that as well...Not bashing just wondering what I am missing. TY

User Image insiderbuyingselling Posted - 09/27/24

$JANX new insider selling: 50000 shares. http://insiderbuyingselling.com/?t=JANX

User Image Theflash88 Posted - 09/26/24

$JANX This thing flip flops more than Kamela!

User Image Rickybruno Posted - 09/17/24

$JANX when are we supposed to get an update on the cancer drug? Will they announce that ahead of time?

User Image PeruvianSwingTrader Posted - 09/17/24

$JANX Watching for entries lower

User Image PeruvianSwingTrader Posted - 09/16/24

$JANX Looks good for a swing to 53.50, if we get above that we could see 56.

User Image momo2021 Posted - 09/16/24

$epix $janx oh look thin skin kamala kevin @dindinn @bulmar always tries to belittle everyone like he is some hedge fund billionaire meanwhile all he does is lose money on everything & steals other peoples research eveybody knows 🤡 & he always gets pummeled with real facts 😂

User Image FlynancialAnalyst Posted - 1 month ago

$JANX $2.61B mc $XBI name & Short Squeeze screen result seeing accumulation off 10 wk SMA & Key $40 level Founder led, 9.42% insider owned Short float % at record lows & trending lower, pct of all funds long shares at record highs & trending higher TrendEdge.app/asset/JANX

User Image Doozio Posted - 1 month ago

$JANX n it’s about to happen in $hrmy during 🧠⏰♾️

User Image ObeCalp Posted - 1 month ago

$JANX Tried to buy call options all day but didn't execute. If there is big news Monday, I'll add to my pile of 'missed again"

User Image Theflash88 Posted - 1 month ago

$JANX The late afternoon drop!

User Image Theflash88 Posted - 1 month ago

$JANX C’mon Merck.

User Image Marketwizwallstreet Posted - 1 month ago

$ACET orbimed and ra capital are 2 of the top 5 bio hedge funds this year have made bank on $tern $spry $janx own 20% of adicet.

User Image seet79 Posted - 1 month ago

$JANX this stock certainly trades like it’s being taken out soon

User Image flytrader1 Posted - 1 month ago

$JANX any reason for this spike? Buyout rumors again?

User Image Thestocktraderhubzee Posted - 1 month ago

WATCHLIST SEP 09 2024.. $GATO CIBC Maintains Outperformer on Gatos Silver, Lowers Price Target to $15 $SHLS Roth MKM Maintains Neutral on Shoals Technologies Gr, Lowers Price Target to $6 $JANX Stifel Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $70 $AMR B. Riley Securities Maintains Buy on Alpha Metallurgical, Lowers Price Target to $336 $GWRE Wells Fargo Maintains Overweight on Guidewire Software, Raises Price Target to $185

User Image Quantumup Posted - 1 month ago

Stifel🏁initiated $JANX at a Buy rating and a $70 PT. Stifel says "We think February's interim phase 1a data for JANX007 (PSMA TCE) suggest it has a high likelihood of becoming an innovative and differentiated therapy for the unmet need in prostate cancer:"

User Image Theflash88 Posted - 08/30/24

$JANX Monday.. I hope…

User Image seet79 Posted - 08/27/24

$JANX when will the buyout finally be announced?

User Image insidemoney Posted - 08/27/24

$JANX Janux Therapeutics 14-Day RSI: 63.5 % from 52-Week Low: +712.7% % from 52-Week High: -30.0% Open Interest: 4,433 % Change: +2% Put/Call Ratio: 1.58 % Change: -3.7%

Analyst Ratings
Cantor Fitzgerald Overweight Sep 16, 24
Stifel Buy Sep 6, 24
HC Wainwright & Co. Buy Aug 19, 24
Scotiabank Sector Perform Aug 9, 24
Cantor Fitzgerald Overweight Aug 8, 24
Wedbush Outperform Aug 8, 24
Scotiabank Sector Perform May 30, 24
HC Wainwright & Co. Buy May 13, 24
Cantor Fitzgerald Overweight May 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Reardon Tighe Acting Chief Financi.. Acting Chief Financial Officer Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/15/23
Lichter Jay Director Director Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/15/23
Avalon Ventures XI, L.P. 10% Owner 10% Owner Nov 13 Buy 5.87 849,854 4,988,643 849,854 11/13/23
ORBIMED ADVISORS LLC Director Director Dec 29 Sell 20.3 40,400 820,120 231,098 12/30/21
Thompson Peter A. Director Director Dec 29 Sell 20.3 40,400 820,120 231,098 12/30/21